Migraine documentary on French TV

On Tuesday, November 3, at 21h05, the health investigation program Enquête de santé on France 5 presents the documentary "Migraine, la fin du casse-tête ?" This program explores the challenges and recent advances in understanding and treating migraines.

Migraine's global impact

Migraine affects nearly 11 million people in France and is the second leading cause of disability worldwide, measured by the number of days people live with the condition. It is a complex disease with a strong genetic component, involving over 120 genes that interact with environmental factors like stress and hormonal changes.

Migraine's gender disparity

The condition affects three times more women than men, largely due to hormonal fluctuations during the reproductive period and perimenopause. This gender imbalance may have led to the underestimation of the condition by society and policymakers, with many sufferers facing invisible pain in the workplace.

Identifying migraine attacks

To distinguish a true migraine from a regular headache, key signs include sensitivity to light and sound, nausea, and a worsening of symptoms during physical activity. These symptoms help differentiate migraine from other types of headaches.

Treatment options and challenges

Effective treatments include lifestyle changes such as regular exercise, hydration, and proper sleep. Older medications are inexpensive but may not be sufficient for severe cases. Botulinum toxin injections and newer anti-CGRP drugs have shown promise but are not reimbursed by France’s Social Security due to their high cost.

Clinical trial for new migraine treatment

A unique clinical trial led by Professor Xavier Moisset is underway, involving 120 patients across five hospitals in France. The study uses transcranial magnetic stimulation, a non-invasive technique that delivers magnetic pulses to the brain to alter pain signals.

Scientific rigor in the trial

To ensure scientific validity, half of the participants receive a placebo treatment that mimics the procedure without actual magnetic stimulation. This approach helps determine whether the treatment has a real effect beyond psychological factors.

Potential of the new therapy

This technology has already shown promise in treating other chronic pain conditions, improving outcomes for about half of patients who had not responded to previous treatments. The Clermont-Ferrand team hopes for similar success with migraine, with minimal side effects reported so far.

Future outlook and message

Professor Xavier Moisset notes that while the results of the study may not be immediate, the long-term goal is to provide sustainable treatment options for migraine patients. The final results are expected in two to three years, after regulatory approvals and data collection. The documentary "Migraine, la fin du casse-tête ?" is broadcast at 21h05 on France 5, presented by Marina Carrère d'Encausse, with the participation of Enora Malagré.